PDCD4 and colonic neoplasm: A mutation in the c-Myc binding site of the MAP4K1 promoter could reduce MAP4K1 promoter activity, and the downregulation of c-Myc can restore MAP4K1 expression and the activation of AP1 in PDCD4-knockdown colon tumor GEO and HT29 cells (24).